Indonesia Gastrointestinal Drugs Market (2024-2030) | Industry, Revenue, Forecast, Size, Outlook, Growth, Value, Analysis, Trends, Companies & Share

Market Forecast By Drug Category (Antiemetic, Acid Neutralizers, Anti-inflammatory, Laxatives & Antidiarrheal, Others), By Route of Administration (Oral, Parenteral, Rectal), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), By Disease Types (Inflammatory Bowel Diseases, Gastroesophageal Reflux Diseases, Others) And Competitive Landscape
Product Code: ETC051368 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Indonesia Gastrointestinal Drugs Market Synopsis

The Indonesia gastrointestinal drugs market is projected to register a CAGR of 5.2% over theperiod (2020-2026). The increasing prevalence of GI diseases such as gastric ulcer Crohn`s disease irritable bowel syndrome and Helicobacter pylori infection are anticipated to boost theof this market. Additionally factors such as rising awareness about healthcare and growing expenditure on health care are expected to drive the demand for gastrointestinal drugs in Indonesia during the review period.

Key Factors Driving the Market

Factors driving itsinclude an increase in gastroenterology disorders among people due to unhealthy dietary habits and sedentary lifestyles; launch of new products; increased focus on clinical trials; presence of unmet needs in terms of treatment options available for GI diseases; availability accessibility of modernized diagnostic services devices; introduction implementation government initiatives like National Health Insurance Program (JKN) by Ministry Of Health - Republic Of Indonesia for making advanced treatments affordable. These factors will bolster up the overall marketduring 2020?2026.

Challenges Facing the Market

High cost associated with novel therapies may restrain drug purchases from patients which is likely hamper overall market expansion overperiod. Moreover stringent regulatory guidelines followed by country?s Drug Control Authority might further challenge manufacturers efforts related to entry their products into global markets specifically Japan or China etc. putting brakes on potentialstreams.

Key Market Players

Major players operating in Indonesia Gastrointestinal Drugs Market amongst them some are Abbott Laboratories Inc. AstraZeneca plcFerring Pharmaceuticals Inc. GlaxoSmithKline PlcMerck Co. Inc. Novartis AGPfizer Inc.

Key Highlights of the Report:

  • Indonesia Gastrointestinal Drugs Market Outlook
  • Market Size of Indonesia Gastrointestinal Drugs Market, 2023
  • Forecast of Indonesia Gastrointestinal Drugs Market, 2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Revenues & Volume for the Period 2020-2030
  • Indonesia Gastrointestinal Drugs Market Trend Evolution
  • Indonesia Gastrointestinal Drugs Market Drivers and Challenges
  • Indonesia Gastrointestinal Drugs Price Trends
  • Indonesia Gastrointestinal Drugs Porter's Five Forces
  • Indonesia Gastrointestinal Drugs Industry Life Cycle
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Drug Category for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Antiemetic for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Acid Neutralizers for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Anti-inflammatory for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Laxatives & Antidiarrheal for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Route of Administration for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Oral for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Parenteral for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Rectal for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Distribution Channel for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Retail Pharmacies for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Online Pharmacies for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Hospital Pharmacies for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Disease Types for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Inflammatory Bowel Diseases for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Gastroesophageal Reflux Diseases for the Period 2020-2030
  • Historical Data and Forecast of Indonesia Gastrointestinal Drugs Market Revenues & Volume By Others for the Period 2020-2030
  • Indonesia Gastrointestinal Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Category
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • Market Opportunity Assessment By Disease Types
  • Indonesia Gastrointestinal Drugs Top Companies Market Share
  • Indonesia Gastrointestinal Drugs Competitive Benchmarking By Technical and Operational Parameters
  • Indonesia Gastrointestinal Drugs Company Profiles
  • Indonesia Gastrointestinal Drugs Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Indonesia Gastrointestinal Drugs Market Overview

3.1 Indonesia Country Macro Economic Indicators

3.2 Indonesia Gastrointestinal Drugs Market Revenues & Volume, 2020 & 2030F

3.3 Indonesia Gastrointestinal Drugs Market - Industry Life Cycle

3.4 Indonesia Gastrointestinal Drugs Market - Porter's Five Forces

3.5 Indonesia Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2020 & 2030F

3.6 Indonesia Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2020 & 2030F

3.7 Indonesia Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2020 & 2030F

3.8 Indonesia Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2020 & 2030F

4 Indonesia Gastrointestinal Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Indonesia Gastrointestinal Drugs Market Trends

6 Indonesia Gastrointestinal Drugs Market, By Types

6.1 Indonesia Gastrointestinal Drugs Market, By Drug Category

6.1.1 Overview and Analysis

6.1.2 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Drug Category, 2020-2030F

6.1.3 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Antiemetic, 2020-2030F

6.1.4 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Acid Neutralizers, 2020-2030F

6.1.5 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Anti-inflammatory, 2020-2030F

6.1.6 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Laxatives & Antidiarrheal, 2020-2030F

6.1.7 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Others, 2020-2030F

6.2 Indonesia Gastrointestinal Drugs Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Oral, 2020-2030F

6.2.3 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Parenteral, 2020-2030F

6.2.4 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Rectal, 2020-2030F

6.3 Indonesia Gastrointestinal Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Retail Pharmacies, 2020-2030F

6.3.3 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Online Pharmacies, 2020-2030F

6.3.4 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Hospital Pharmacies, 2020-2030F

6.4 Indonesia Gastrointestinal Drugs Market, By Disease Types

6.4.1 Overview and Analysis

6.4.2 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Inflammatory Bowel Diseases, 2020-2030F

6.4.3 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Gastroesophageal Reflux Diseases, 2020-2030F

6.4.4 Indonesia Gastrointestinal Drugs Market Revenues & Volume, By Others, 2020-2030F

7 Indonesia Gastrointestinal Drugs Market Import-Export Trade Statistics

7.1 Indonesia Gastrointestinal Drugs Market Export to Major Countries

7.2 Indonesia Gastrointestinal Drugs Market Imports from Major Countries

8 Indonesia Gastrointestinal Drugs Market Key Performance Indicators

9 Indonesia Gastrointestinal Drugs Market - Opportunity Assessment

9.1 Indonesia Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2020 & 2030F

9.2 Indonesia Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2020 & 2030F

9.3 Indonesia Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2020 & 2030F

9.4 Indonesia Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2020 & 2030F

10 Indonesia Gastrointestinal Drugs Market - Competitive Landscape

10.1 Indonesia Gastrointestinal Drugs Market Revenue Share, By Companies, 2023

10.2 Indonesia Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All